Speakers
Aaron Arvey, Ph.D.
Director, Machine Learning
Third Rock Ventures
Joshua Berlin
Head of Business Development
BioCentury Inc.
Peter Bisgaard
Managing Director
Nan Fung Life Sciences, Pivotal Life Sciences
Leonard Blum
President & CEO
XWPharma
Jeff Calcagno
Head, JLABS Bay Area
Johnson & Johnson Innovation
Chris Carpenter, M.D., Ph.D.
Executive Partner, Private Equity
Sofinnova Investments
Tony Chen
Partner
Jones Day
Michelle Chen, Ph.D.
Board Member, BayHelix &
Chief Business Officer, Insilico Medicine
Tom Chittenden, PhD, DPhil, PStat
Chief Scientific Officer, President of R&D, and SAB Chairman
BioAI Health
Billy Cho
CFO
Zai Lab Ltd.
Shelley Chu, M.D., Ph.D.
Partner, Head of Biotech
Lightspeed Ventures
Mark Cohen
Distinguished Senior Fellow
University of California at Berkeley, and former Senior IP Attache, U.S. Embassy - China
Jeff Cranmer
Executive Editor and Head of Daily Global Intelligence
BioCentury Inc.
J. Jean Cui
CEO
BlossomHill Therapeutics
Eric Davis
Chief Legal Officer
BioMarin Pharmaceutical Inc.
Arvinder Dhalla, Ph.D.
VP Clinical Development
Rani Therapeutics
Vishal Doshi
Chairman & CEO
AUM Biosciences
Lisa Feng
Chief Business Officer & CFO
Zhaoke Ophthalmology Ltd.
Simone Fishburn, Ph.D.
Vice President & Editor in Chief
BioCentury Inc.
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Tao Fu
Venture Partner
Frazier Healthcare Partners
Deeona Gaskin
Partner
Sidley
Simeon George, M.D.
CEO & Managing Partner
SR One
Fabian Gerlinghaus
Co-Founder & CEO
Cellares
David Goldstein, Ph.D.
CEO
Actio Biosciences Inc.
Angus Grant
Chief Business Executive
BeiGene Ltd
Gevorg Grigoryan, Ph.D
Co-Founder & Chief Technology Officer
Generate Biomedicines
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
Paul Hastings
CEO
Nkarta Therapeutics
Kathy He
Chief Executive Officer
Cargene Therapeutics Inc.
Jennifer Heller, Ph.D.
Partner
McKinsey & Company
Thomas Herget, Ph.D.
Head, Silicon Valley & China Innovation Hubs
Merck Group
Echo Hindle-Yang
Founder & CEO
MSQ Ventures
Paul Hoerbelt, Ph.D.
Associate
Illumina Ventures
James Huang
Founding Managing Partner, Panacea Healthcare Venture &
Managing Partner, KPCB China
Ying Huang, Ph.D.
CEO
Legend Biotech
Henk Joos, Ph.D.
General Manager
Agio Capital & Business Solutions
Melita Sun Jung
Chief Business Officer
Structure Therapeutics
Lan Kang
Senior Managing Director
CBC Group
Wei KANG
Executive Advisor
RDPAC (R&D-Based Pharmaceutical Association Committee)
Sree Kant
Founder & CEO
Bakx Therapeutics
David Kappos
Partner
Cravath, Swaine & Moore LLP, and former Under Secretary of Commerce & Director, United States Patent and Trademark Office
Patricia Keegan, M.D.
Chief Medical Officer
Junshi Biosciences
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice
McKinsey & Company
Olivier Leclerc
Senior Partner
McKinsey & Company
Jeff Legos
EVP & Global Head of Oncology and Hematology Development
Novartis
Arjen Lemmen
Vice President, Corporate Development & Strategy
argenx
John Lepore, M.D.
Senior Vice President and Head of Research
GlaxoSmithKline
Nisa Leung
Managing Partner
Qiming Venture Partners
Hui Li, Ph.D
Founder, President & CEO
Adcentrx Therapeutics
Judith Li
Partner
LAV
Qiutang Li, Ph.D.
Chief Scientific Officer
Neurophth
Charlene Liao, Ph.D.
President & CEO
Immune-Onc Therapeutics
James C. Lin
Partner
Davis Polk
Ke Liu, M.D., Ph.D.
Chief Development Officer
Marengo Therapeutics
Xin Liu
Partner
Eight Roads Ventures China
Mark Lotter
Founder & CEO
Nuance Pharma
Yvonne Lu
Co-Lead, Global Biopharma Practice
Russell Reynolds Associates
Roger Luo, Ph.D.
Chief Development Officer
Overland Pharmaceuticals
David Meek
CEO
Mirati Therapeutics Inc.
Scott Megaffin
CEO
Adiso Therapeutics, Inc.
Nishit Modi, Ph.D.
Senior Vice President
Protagonist Therapeutics
Barry Murphy
Chief Commercial Officer
Novotech
Carolyn Ng
Partner & Managing Director
TPG
Kevin Oliver, Ph.D.,
Chief Operating Officer
U.S. and Europe & SVP, Global Head of BD&L, Simcere Pharmaceutical Group Ltd.
John Oyler
Founder, Chairman & CEO
BeiGene Ltd.
Wendy Pan, Ph.D.
Partner
Goodwin
Rajesh Parekh, Ph.D.
Senior Partner
McKinsey & Company
Dianna Qian
Partner
Pivotal Bioventure China
Kiran Reddy, M.D.
Senior Managing Director
Blackstone
David M. Reese, M.D.
Executive Vice President, Research and Development
Amgen
Sameer Rohatgi
Venture Partner
Lyfe Capital
Blake Salisbury
SVP, Business Development
Innovent Biologics
Perika Sampson
Global Head of Inclusion and Diversity
Gilead
Joan Shen, M.D., Ph.D.
Founder & CEO
Neushen Therapeutics Inc.
Riad Sherif, M.D.
CEO
Oculis
Michael Shi M.D., Ph.D.
Executive Vice President, Head of R&D and Chief Medical Officer, China
HUTCHMED
Ruilin Song
Executive President
PhIRDA (China Pharmaceutical Innovation and Research Development Association)
Kiersten Stead, Ph.D.
Managing Partner
DCVC Bio
Lingshi Tan, Ph.D.
Chairman & CEO
Caidya
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Stewart Walker
President & Director
Acclime USA
Jonathan Wang
Chief Business Officer
Zai Lab Ltd.
Xuelin (Steve) Wang
Partner
Davis Polk
Jonathan Wang, Ph.D.
Chairman and CEO - Inmagene；
Co-founder, BayHelix
Lai Wang, Ph.D.
Global Head of R&D
BeiGene
Marrietta Wu, Ph.D.
Managing Director
Quan Capital
Ning Xia, Ph.D.
Founder & CEO
Chemical.AI
Stella Xu, Ph.D.
Managing Partner
Quan Capital
Phoebe Yan
Partner
Paul Hastings LLP
Steve Yang, Ph.D.
Co-CEO
WuXi AppTec
Ying Yang, Ph.D.
CEO
LabDirect
Debra Yu, M.D.
Partner & COO
Panacea Venture
Guo-Liang Yu, Ph.D.
Chairman & CEO, Apollomics Inc. and
Chairman, BayHelix
Peony Yu, M.D.
Chief Medical Officer
Apollomics Inc.
Jimmy Zhang, Ph.D.
Former Chairman, BayHelix, and Head of Business Development
Frontier Biotechnologies
Fangning ZHANG
Partner
McKinsey & Co.
Ed Zhang
Co-founder and CEO
Overland Pharmaceuticals
Shirley Zhao M.D.
Co-Founder & CEO
Bennu Biotherapeutics
Lihan Zhou, Ph.D.
Co-Founder & CEO
MiRXES Pte. Ltd.
Sarah Zhu
Of Counsel
Paul Hastings LLP